Article

A Framework to Predict the Applicability of Gene Signatures for Improving Prognostic Prediction

2021-06-02

Abstract excerpt

To improve cancer precision medicine, prognostic and predictive biomarkers are critically needed to aid physicians in deciding treatment strategies in a personalized fashion. Due to the heterogeneous nature of cancer, most biomarkers are expected to be valid only in a subset of patients. Furthermore, there is no current approach to determine the applicability of biomarkers. In this study, we propose a framework to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f2dcb5e6-d47f-5504-a857-59285e58c145
DOI: 10.21203/rs.3.rs-571421/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Framework to Predict the Applicability of Gene Signatures for Improving Prognostic PredictionDOI 10.21203/rs.3.rs-571421/v1Read

Evaluation and comparison of different breast cancer prognosis scores based on gene expression dataSemantic proximity Read

Machine learning to construct an mRPS risk prognostic model for directing immunotherapy in patients with breast cancer based on the mCAF signature genesSemantic proximity Read

Construction and validation of a prognostic risk model for breast cancer based on protein expressionSemantic proximity Read

Methylation-To-Expression Feature Models of Breast Cancer Accurately Predict Overall Survival, Distant-Recurrence Free Survival, And Pathologic Complete Response in Multiple CohortsSemantic proximity Read

Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendationsSemantic proximity Read

Re-evaluation of publicly available gene-expression databases using machine-learning yields a maximum prognostic power in breast cancerSemantic proximity Read

ENCAPP: elastic-net-based prognosis prediction and biomarker discovery for human cancersSemantic proximity Read

Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.Semantic proximity Read

Prognostic Predictors Do Not Equate to Predictors of Chemotherapy Benefit in HR-Positive, HER2-Negative Breast Cancer: A Population-Based StudySemantic proximity Read

Facilitating “Omics” to Phenotype Classification Using a User-Friendly AI-Driven Platform: Application to Cancer PrognosticsSemantic proximity Read

Improved prediction of breast cancer outcome by identifying heterogeneous biomarkersSemantic proximity Read

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.Semantic proximity Read